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Background: Regional variation in the intensity of end-of-life care contributes significantly to the overall cost of
health care. The interpretation of patterns of regional variation hinges, in part, on appropriate adjustment for
regional variation in demographic variables such as age, race, sex, and rural vs. urban residence. This study
examined regional variation in discontinuation of dialysis prior to death in the US, after adjustment for key
demographic variables.
Methods: In this retrospective cohort study of the 2009 United States Renal Data System (USRDS) database we
examined discontinuation of dialysis prior to death among deceased adult patients with end-stage renal disease
(ESRD) from the 50 states and the District of Columbia. The discontinuation of dialysis prior to death was
ascertained from the Centers for Medicare & Medicaid Services form 2746 (ESRD Death Notification form). We used
logistic regression to estimate the log-odds of discontinuation of dialysis with ESRD network as independent
variable adjusted for urban–rural status, demographic and treatment variables.
Results: The study cohort included 715,605 deceased ESRD patients; for 176,021 of whom (24.6%) dialysis was
discontinued prior to death. Dialysis was discontinued at higher rates for women than for men (26.3% vs. 23.0%,
p < 0.001) and for whites than for blacks (29.5% vs. 14.7%, p < 0.001). Significant regional variation in dialysis
discontinuation prior to death was noted after adjustment for age, race and rural–urban status: rates of
discontinuation in the Upper Midwest and Mountain regions were more than double the rates in Southern and
Coastal regions. This pattern parallels the regional pattern of end-of-life health service utilization documented in the
Dartmouth Atlas and other studies.
Conclusions: Discontinuation of dialysis prior to death was common in the US between 1995 and 2009. The
deaths of nearly one quarter of chronic dialysis patients followed a decision to discontinue dialysis. Significant
regional variation in discontinuation rates exists after adjusting for age, race, sex, and rural–urban status. Further
research and analysis is needed on the cultural and economic factors that affect regional variation in health services
utilization, especially in regard to the use of expensive medical services near the end of life.
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Regional variation in cost and intensity of care has
attracted the attention of researchers and health policy
leaders [1-3]. As concerns about the cost of health care
have grown, regional variation has been examined more
closely. Overall, regional health care expenditures do not
correlate well with quality of care. In 2003, Fisher et al.
found that although Medicare enrollees in higher-* Correspondence: cgessert@eirh.org
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reproduction in any medium, provided the orspending regions received more care than those in
lower-spending regions, they did not have better out-
comes or satisfaction with care [4,5].
Regional variation in end-of-life care is of special inter-
est, both because of the substantial Medicare expendi-
tures in the last year of life [6-9], and because of
concerns about overuse of services that may be both
burdensome and offer little benefit to dying patients
[10]. Significant regional variation has been documented
in the use of feeding tubes [10,11], hospitalizations late
in life [10], intensive care use in the last month of lifeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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overall expenditures on end-of-life care [5,6]. The Dart-
mouth Atlas of Health Care documented substantial re-
gional differences in the use of inpatient care, intensive
care, physicians’ visits, and other services at the end of
life, and concluded that “…to the extent that end of life
issues are addressed in practice, they are resolved in
ways that depend on where the patient happens to live,
not on the patient’s preferences or the power to extend
life” [13]. Many medical services – such as hospitaliza-
tions and consultations with specialists – are used more at
the end of life in areas of the South and along the urban
corridors on the East and West Coasts, when compared
with use in Midwestern and Mountain regions [12].
The observed patterns of regional variation in health
care utilization in the US may be affected by many
factors, including the demographic and cultural charac-
teristics of the regions’ populations; differences in the
prevalence or severity of health problems, especially
chronic diseases; and variations in practice patterns [4].
Greater utilization of medical care near the end of life
has been associated with non-white race [6,8,10,14,15],
younger age at the time of death [16-18], urban resi-
dency [19,20], and lack of advance directives [9]. Many
of these factors also co-vary in populations. For example,
black Americans make up a higher percentage of urban
than rural populations, and complete advance directives
at a lower rate than white Americans.
Several of the demographic characteristics associated
with greater intensity of care at the end of life, such as
non-white race and lower age at the time of death, are
also more prevalent in the regions of the country known
to have more intensive end-of-life care patterns. There-
fore, adjustment for race, age, and rural–urban residence
is necessary when assessing the magnitude of regional
variation in medical care utilization at the end of life.
Data on end-stage renal disease (ESRD) and on dis-
continuation of dialysis prior to death may be used to
examine regional variation in the end-of-life health care.
In 1986, Neu and Kjellstrand reported that 22% of
all ESRD deaths in a large regional dialysis program
followed the discontinuation of dialysis therapy [21].
Over the ensuing 25 years, the discontinuation of dialy-
sis prior to death has been examined extensively in both
the US and Europe [22]. The proportion of ESRD deaths
preceded by discontinuation of dialysis has been slowly
rising [23]. Some regional variation in the discontinuation
rates has been documented. For example, the percentage
of ESRD deaths preceded by discontinuation of dialysis in
the ESRD Network of New England was found to be
32-35% in 2001, when the national rate was 24% [24,25].
Regional variation in dialysis discontinuation prior to
death may be affected by the same demographic factors
that have been found to affect other end-of-life carepatterns, especially age and race. The average age of dia-
lysis patients varies significantly by region, with older
populations of dialysis patients in areas such as New
England, the Upper Midwest, and southern Florida than
in the rest of the country [26]. The race of dialysis pa-
tients also varies significantly by region, with greater
proportions of non-white patients in the South and
along the East and West Coasts. The proportion of dia-
lysis patients who reside in rural areas may also affect
discontinuation rates, as rural populations have been
found to use less intensive end-of-life care than urban
counterparts [7,20]. Accordingly, regional dialysis dis-
continuation rates should be adjusted for age, race, and
rural–urban residence.
In fact, the demographic factors associated with forgo-
ing other medical interventions near the end of life are
associated with dialysis discontinuation as well. Discon-
tinuation rates are higher in whites than in other racial
groups [27-29]. Discontinuation is also more common
among women [23,29], among patients who are
widowed or divorced [30], and those who are institution-
alized [30,31]. Patients with depression [32], dementia
[23,31,33] or malignancy [23] are more likely to discon-
tinue dialysis, as are those with diabetes [29,34,35].
Higher pain and discomfort levels are also associated
with higher discontinuation rates [30].
This study was undertaken to improve understanding
of regional variation in health care intensity at the end
of life, and to quantify regional variation in end-of-life
care after adjusting for demographic differences between
regions. Specifically, we examine regional variation in
discontinuation of dialysis, after adjusting for race, age,
sex and rural–urban residence.
Methods
Data sources and definitions
In this retrospective study we used data from the United
States Renal Data System (USRDS), a national data regis-
try for ESRD in the US. The USRDS incorporates longi-
tudinal demographic and clinical data on all patients in
the US Medicare ESRD program. An ESRD patient is a
person with chronic renal failure who requires renal re-
placement treatment (dialysis or transplant) that has been
certified by a physician at onset of ESRD, or when other
evidence of chronic dialysis or a kidney transplant exists.
Patients with acute renal failure who subsequently recover
renal function are excluded from the USRDS [36].
Several USRDS standard analysis files were used in this
study. The Patient File contains basic demographic in-
formation and ESRD-related data. The Treatment His-
tory File contains detailed treatment history including
treatment periods, treatment modality and dialysis pro-
vider. The Residence File contains longitudinal records
of ESRD patients’ residence and was used to determine
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death. Records for individual patients were linked using
USRDS identification numbers.
The ESRD Network Program, directed by the Centers
for Medicare & Medicaid Services, consists of 18 ESRD
networks, responsible for US states, territories and the
District of Columbia. These networks service geographic
areas based on the number and concentration of ESRD
beneficiaries. We elected to use the 18 ESRD networks
as the units for analysis of regional variation as the net-
works are used extensively in monitoring of the quality
of chronic kidney disease care in the US. US territories
were excluded from the analysis.
ZIP-code level files from the WWAMI Rural Health
Research Center were used to define the Rural–urban
Commuting Area (RUCA) codes [37] for each ESRD pa-
tient included in the study population. Based on stand-
ard US Census Bureau urbanized area and urban cluster
definitions combined with commuter information, the
RUCA codes classify all Census tracts by rural and urban
status and relationships. Due to changes in the RUCA
codes overtime, the level of rurality was estimated by
linking ZIP codes from the Residence File to the version
of ZIP code-level approximation RUCA codes closest to
patient’s time of death: those deceased in 1995–1999
were assigned the version 1.11 RUCA codes based on
1990 Census commuting areas with 1998 ZIP codes [38].
Those deceased in 2000–2004 were assigned the version
2.0 RUCA codes based on 2000 Census commuting data
and 2004 ZIP codes; and those deceased in 2005–2009
were assigned the version 2.0 RUCA codes with 2006
ZIP codes. The RUCA algorithm creates mutually exclu-
sive categories that represent population density and
affinity to nearby urban centers. We used 4-level aggre-
gation of the RUCA codes: urban, large rural city/town,
small rural town, or isolated small rural town to describe
the level of rurality within the study population. The two
categories “small rural town” and “isolated small rural
town” were further collapsed into one category resulting
in 3-level aggregation for the analysis.
Study population
We limited the study population to patients enrolled in
the Medicare ESRD program who resided in the 50
states of the US and the District of Columbia and who
died between 1995 and 2009, inclusively. The date range
was determined based on the availability of data on dia-
lysis discontinuation prior to death. The death of an en-
rollee in the ESRD program is reported to the USRDS
using Centers for Medicare & Medicaid Services form
2746. While the USRDS began using forms that pro-
vided an opportunity for recording whether or not dialy-
sis had been discontinued prior to death in 1990, in the
first years of the new reporting system (prior to 1995),discontinuation status was recorded on less than 20% of
the forms. Between 1995 and 2000, more than 50% of
forms had information regarding discontinuation status,
and after 2000 nearly 90% of forms reported discontinu-
ation status. In view of the uneven recording of discon-
tinuation data from 1990 to 1994, these years were
excluded from the analysis.
Additional criteria for inclusion were valid age and
USRDS first service date, age at least 40 years old at the
time of dialysis onset, length of dialysis prior to death at
least 90 days, and known discontinuation of dialysis sta-
tus. Patients with unknown age, sex, or race were ex-
cluded as were those for whom rural–urban status could
not be determined. Patients who had a kidney transplant
and who did not resume dialysis treatment prior to
death were also excluded from the study population.
Outcome variables and covariates
The outcome variable was discontinuation of dialysis prior
to death. The primary independent variable for evaluation
of regional variation in the rates of dialysis discontinuation
prior to death was the ESRD network. Continuous covari-
ates of interest were age at death, year of death, and years
on dialysis. Categorical covariates included race (black,
white, or other), sex (male or female), last treatment mo-
dality prior to death (hemodialysis or peritoneal dialysis),
and RUCA-defined rurality (urban, large rural town, or
small rural town/isolated small rural town).
Statistical analysis
We used descriptive statistics to characterize the entire
study population and stratified by the discontinuation of
dialysis status, using means, standard deviations (SD)
and medians for continuous variables and frequencies
for categorical variables. We assessed bivariate relation-
ships between patient characteristics and dialysis discon-
tinuation status by using t-tests for means and Wilcoxon
rank-sum tests for medians of continuous variables and
chi-squared tests for categorical variables. The propor-
tion of patients with discontinued dialysis by race and
5-year age group was calculated to ascertain the rela-
tionship between dialysis discontinuation, race and age.
We estimated the log-odds (logit) of discontinuation
of dialysis with a logistic regression model with the
main-effect explanatory variables given above. Empirical
investigation of the raw data suggested a cubic effect for
age at death on the log-odds of discontinuation of dialy-
sis. We hypothesized that the effect of age at death may
differ according to race and years on dialysis. For these
reasons, the higher-order terms of quadratic and cubic
age at death and three interaction terms of age at death
by race, and years on dialysis were also included in the
model. The ESRD network with the estimated probabil-
ity of dialysis discontinuation closest to the median
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was chosen as the reference in the estimation of odds ra-
tios. Least-squares means (LS-means) of the log-odds for
each network at the average value for each covariate in
the model were also estimated. Following the inverse
logit transformation, an estimate of the probability of
discontinuation of dialysis as well as corresponding 95%
confidence intervals, given the covariates in the model,
was obtained for each network. Estimated probabilities
of dialysis discontinuation for ESRD networks over the
entire 15-year period from the model were grouped into
quintiles and used for visual presentation of regional
variation in the dialysis discontinuation.
The authors had full access to the data. All analyses
were conducted by using SAS, version 9.2 or later2009 USRDS 
all ESRD p
n = 2,260
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Figure 1 Study cohort selection. USRDS = United States Renal Data Syst
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We identified 715,605 ESRD patients who died between
1995 and 2009 and had dialysis at least for 90 days prior
to death, with known status of dialysis discontinuation.
The selection of the study cohort is summarized in
Figure 1. Table 1 reflects the demographic and dialysis-
related characteristics of the study population by dialysis
discontinuation status. Overall, the patients’ mean age at
the time of death was 70.0 years (SD = 11.3); 47.7% were
women; 65.5% were white, and 21.4% resided in rural
areas. Hemodialysis was the last dialysis modality for theDatabase: 
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Table 1 Study population: characteristics of ESRD patients by dialysis discontinuation status prior to death
(1995–2009)






No. of patients 715,605 176,021 539,584
Age at dialysis onset, mean (SD) 66.7 (11.92) 70.1 (11.20) 65.6 (11.94)
Age at death, mean (SD) 70.0 (11.34) 73.2 (10.65) 69.0 (11.37)
Age at death, n (%)
40 – 59 140,670 (19.7) 21,133 (12.0) 119,537 (22.2)
60 – 69 179,489 (25.1) 36,937 (21.0) 142,552 (26.4)
70 – 79 235,667 (32.9) 63,532 (36.1) 172,135 (31.9)
80+ 159,779 (22.3) 54,419 (30.9) 105,360 (19.5)
Male sex, n (%) 374,605 (52.3) 86,301 (49.0) 288,304 (53.4)
Race, n (%)
White 468,979 (65.5) 138,203 (78.5) 330,776 (61.3)
Black 212,576 (29.7) 31,290 (17.8) 181,286 (33.6)
Asian 20,459 (2.9) 3,713 (2.1) 16,746 (3.1)
American Indian 9,479 (1.3) 2,168 (1.2) 7,311 (1.4)
Other 4,112 (0.6) 647 (0.4) 3,465 (0.6)
Location,* n (%)
Urban 562,156 (78.6) 133,957 (76.1) 428,199 (79.4)
Large rural city/town 74,316 (10.4) 20,758 (11.8) 53,558 (9.9)
Small rural town 46,060 (6.4) 12,105 (6.9) 33,955 (6.3)
Isolated small rural town 33,073 (4.6) 9,201 (5.2) 23,872 (4.4)
Hemodialysis,** n (%) 672,623 (94.0) 166,308 (94.5) 506,315 (93.8)
Years on dialysis, mean (SD) 3.2 (2.90) 3.0 (2.77) 3.3 (2.94)
Years on dialysis, median (Q1, Q3) 2.4 (1.1, 4.5) 2.2 (0.9, 4.2) 2.5 (1.1, 4.6)
All of the differences between dialysis discontinuation groups are statistically significant at p < 0.001.
*ESRD patient residence based on RUCA codes (zip code approximation of Census tracks).
**Last treatment modality recorded prior to death.
ESRD = End Stage Renal Disease; SD=Standard Deviation; RUCA = Rural Urban Commuting Areas; Q1 and Q3 = first and third quartiles.
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lysis was 2.4 years (Table 1).
Dialysis was discontinued prior to death in 176,021
(24.6 %) ESRD patients (Figure 1). Discontinuation was
more frequent in those who were age 70 or older than
in those under age 70 (29.83% vs. 18.14%, p < 0.001),
and more frequent among women than men (26.3% vs.
23.0%, p < 0.001). Whites discontinued dialysis prior to
death more frequently than blacks (29.5% vs. 14.7%, p <
0.001) or patients of other races (29.5% vs. 19.2%, p <
0.001). Residents of small and isolated rural towns
discontinued dialysis at a slightly higher rate than resi-
dents of urban areas and large towns (26.9% vs. 24.3%,
p < 0.001). The overall unadjusted rate of discontinu-
ation of dialysis rose over the 15 years examined (p <
0.001). For example, the rate of dialysis discontinuation
was 21.5% in 1995, 24.4% in 2002, and 27.8% in 2009.
While the rates of dialysis discontinuation differed byrace (p < 0.001) and age (p < 0.001), they consistently
rose with age for all races (Figure 2). In each age group,
blacks had lowest rates of dialysis discontinuation, and
whites had the highest.
In each of the years examined, patients whose dialysis
was discontinued prior to death were older on average –
both at dialysis onset and at death – than those who
died while still receiving dialysis. For example, the mean
age at onset of dialysis among patients for whom dialysis
was eventually discontinued prior to death was 64.5
years (SD = 10.6) in 1995, 69.9 years (SD = 11.1) in
2002, and 70.6 years (SD = 11.4) in 2009. However, over
the examined 15 years, the mean age at onset of dialysis
changed little for patients who were still on dialysis at
the time of death: 64.8 years (SD = 11.3) in 1995, 65.7
years (SD = 11.9) in 2002, and 65.6 years (SD = 12.2) in
2009. The mean age at death increased steadily for pa-
tients for whom dialysis was discontinued: 71.3 years
Figure 2 Discontinuation of dialysis prior to death by race and age group. Shown are unadjusted proportions of end-stage renal disease
patients with discontinued dialysis (1995–2009).
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74.1 years (SD = 10.8) in 2009. Similar pattern in the mean
age at death was observed for those for whom dialysis was
not discontinued: 67.9 years (SD = 10.8) in 1995, 69.0
years (SD = 11.3) in 2002, and 69.3 years (SD = 11.6) in
2009. The time on dialysis had similar temporal trends.
The mean length on dialysis for those with discontinu-
ation of dialysis prior to death was 2.7 years in 1995, 2.9
years in 2002, and 3.3 years in 2009; while the meanTable 2 Regional variation in dialysis discontinuation prior to
ESRD network (US states
included in the network)
Observed probability of
discontinuation (95% CI)
18 (Southern CA) 0.171 (0.167, 0.174)
2 (NY) 0.183 (0.180, 0.187)
3 (NJ) 0.193 (0.188, 0.198)
10 (IL) 0.202 (0.198, 0.206)
13 (AR, LA, OK) 0.205 (0.201, 0.209)
8 (AL, MS, TN) 0.199 (0.196, 0.203)
5 (DC, MD, VA, WV) 0.207 (0.204, 0.211)
6 (GA, NC, SC) 0.205 (0.202, 0.208)
9 (IN, KY, OH) 0.253 (0.250, 0.257)
4 (DE, PA) 0.269 (0.264, 0.274)
14 (TX) 0.250 (0.246, 0.254)
17 (HI, Northern CA) 0.248 (0.243, 0.253)
7 (FL) 0.257 (0.253, 0.261)
12 (IA, KS, MO, NE) 0.312 (0.307, 0.317)
15 (AZ, CO, NM, NV, UT, WY) 0.319 (0.314, 0.325)
1 (CT, MA, ME, NH, RI, VT) 0.361 (0.355, 0.368)
11 (MI, MN, ND, SD, WI) 0.332 (0.328, 0.336)
16 (AK, ID, MT, OR, WA) 0.395 (0.388, 0.401)
1Predicted probability of discontinuation of dialysis from LS-means estimates from
included in the model);
2The odds of dialysis discontinuation for a ESRD network relative to reference netw
*Reference, network 9 with the rate of dialysis discontinuation closest to the media
ESRD = End-Stage Renal Disease; CI = confidence interval.length on dialysis for those who continued to receive dia-
lysis was 3.0 years in 1995, 3.2 years in 2002, and 3.6 years
in 2009.
The rates of dialysis discontinuation prior to death
varied markedly by region of the country and are listed
in Table 2. The observed (unadjusted) probability of dia-
lysis discontinuation in the regions with highest rates
(0.39 in network 16 – Alaska, Idaho, Montana, Oregon
and Washington, and 0.36 in network 1 – New England)death in ESRD patients by ESRD network (1995–2009)
Estimated probability1
of discontinuation (95% CI)
Adjusted odds
ratio2 (95% CI)
0.154 (0.151, 0.158) 0.59 (0.57, 0.61)
0.170 (0.167, 0.174) 0.66 (0.64, 0.69)
0.187 (0.182, 0.191) 0.74 (0.72, 0.77)
0.194 (0.190, 0.199) 0.78 (0.75, 0.81)
0.218 (0.214, 0.223) 0.90 (0.87, 0.93)
0.220 (0.216, 0.224) 0.91 (0.88, 0.94)
0.226 (0.222, 0.230) 0.94 (0.91, 0.97)
0.236 (0.233, 0.240) 1.00 (0.97, 1.03)
0.236 (0.233, 0.240) 1.00*
0.238 (0.234, 0.243) 1.01 (0.98, 1.04)
0.240 (0.236, 0.245) 1.02 (0.99, 1.05)
0.241 (0.236, 0.247) 1.03 (0.99, 1.06)
0.250 (0.246, 0.254) 1.08 (1.05, 1.11)
0.288 (0.283, 0.294) 1.31 (1.27, 1.35)
0.303 (0.297, 0.308) 1.40 (1.36, 1.45)
0.313 (0.307, 0.320) 1.48 (1.43, 1.53)
0.315 (0.311, 0.319) 1.48 (1.45, 1.52)
0.365 (0.358, 0.371) 1.85 (1.79, 1.92)
the logistic regression (i.e. estimated at average values of all covariates
ork 9;
n of estimated probability for the overall study population;
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rates (0.17 in network 18 – Southern California, and
0.18 in network 2 – New York). The magnitude of re-
gional variation decreased somewhat after adjusting for
the covariates in the multivariate model, but an approxi-
mate 2:1 ratio between the highest and lowest networks
remained (0.37 in network 16 vs. 0.15 in network 18).
The probabilities of dialysis discontinuation estimated
from the logistic regression at average values of all
covariates included in the model are shown in Table 2.
The estimated probability for network 9 (Indiana,
Kentucky and Ohio) – 0.236, was closest to the median
estimated probability for the overall study population
(0.233), and was used as a reference level for estimating
odds ratios. The odds of discontinuation of dialysis prior
to death for networks 6 (Georgia, North Carolina, South
Carolina), 14 (Texas) and 17 (Hawaii and Northern
California) did not statistically differ from the reference;
the odds for the remaining networks were statistically
significantly different relative to network 9. The prob-
abilities of dialysis discontinuation, adjusted for covari-
ates and grouped into quintiles over the entire 15 years
of the study, are reflected in Figure 3.
Discussion
The pattern of regional variation of dialysis discontinu-
ation demonstrated in this study parallels the pattern of
end-of-life care documented in the Dartmouth Atlas
[13] and in other studies on variation in the intensity of
care at the end-of-life [5,6,10]. The national maps fromFigure 3 Regional variation in discontinuation of dialysis in the US. Sh
end-stage renal disease networks (1995–2009), adjusted for covariates and
while networks 1, 11 and 16 populate the highest quintile.these studies present a consistent picture, with more in-
tensive use of services in the South and in urban areas
of the East and West Coasts, and less intensive use in
the Upper Midwest, Mountain states, and New England.
A study by Hirth et al. on geographic variation in
Medicare ESRD expenditures [39] documented a similar
national pattern, with the lowest ESRD expenditures in
communities from the areas found to have high discon-
tinuation rates in the current study. Similarly, O’Hare
et al. found that ESRD patients living in areas of high
end-of-life care intensity were less likely to have
discontinued dialysis before death [40]. Overall, dialysis
discontinuation rates provide a measure of intensity of
end-of-life care that is consistent with measures used in
prior work on geographic variation. The current study
also demonstrates that significant regional variation
persists after adjustment for demographic differences
between regions.
The documentation of significantly lower rates of dia-
lysis discontinuation in some regions of the country does
not, in itself, mean that patient care in these regions is
unnecessarily aggressive or intensive. However, the re-
gional variation documented in the current study is not
an isolated finding; the pattern of regional variation in
intensity of end-of-life care is consistent. Whether the
question is the use of feeding tubes in elderly patients
with cognitive impairment [11], nursing home residents
receiving potentially burdensome medical interventions
near the end of life [10], or the overall level of intensity
of medical care at the end of life [5], the same regionsESRD Networks: 
1 - CT, MA, ME, NH, RI, VT
2 - NY
3 - NJ
4 - DE, PA
5 - DC, MD, VA, WV
6 - GA, NC, SC
7 - FL
8 - AL, MS, TN
9 - IN, KY, OH
10 - IL
11 - MI, MN, ND, SD, WI
12 - IA, KS, MO, NE
13 - AR, LA, OK
14 - TX
15 - AZ, CO, NM, NV, UT, WY
16 - AK, ID, MT, OR, WA
17 - HI, No. CA
18 - So. CA
.365
own are estimated probabilities of dialysis discontinuation in the US
grouped into quintiles. Networks 2, 3 and 18 are in the lowest quintile,
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expensive) end-of-life care. Future research directed at
improving our understanding of the reasons why these
regional variations exist is needed. Clearly, such variation
cannot be explained by demographic differences between
regions alone, as demonstrated by the current study.
We found that, overall, the average age of incident dia-
lysis patients rose steadily over the 15 years of the study.
However, there was little change in the age at dialysis
onset among patients who remained on dialysis until
death, while the age at dialysis onset of those whose dia-
lysis was eventually discontinued rose significantly. This
finding suggests that the use of dialysis in ever-older pa-
tients should be monitored closely, as co-morbidity and
quality-of-life considerations are more prevalent in older
patients, and contribute to many dialysis discontinuation
decisions. The early start of dialysis in elderly patients,
in particular, should be examined closely, as it is one of
the principal factors contributing to the greying of the
dialysis population, and does not consistently provide a
mortality, morbidity or quality of life benefit [41-43].
In this study, we used the ESRD networks to examine
regional variation in dialysis discontinuation rates. We
recognized that the use of large geographic regions in
the analysis obscured important small area variation
within regions. However, we elected to use these large –
mostly multi-state – regions with the goal of examining
variability above the level of practice, institution, or
community. The finding of significant regional variation
after adjusting for age, race and rural–urban residence is
interesting because other factors that have been found
to be associated with discontinuation – female sex
[23,29], malignancy [23], dementia [23], depression [32],
and pain [44] – are not likely to vary substantially from
region to region. The observed variation suggests that
broader cultural variables – education, religion, values,
and tradition – may have to be examined to arrive at a
better understanding of regional variations in care. In ef-
forts to rein in health care costs, policy makers will need
to consider both small area variation – often reflecting
local, institutional or practice patterns that lead to vari-
ation – and regional variation as documented in the
current study. Future research should be directed not
only at how small area differences in medical practice
affect end-of-life care, but on how regional traditions
and culture affect patterns and preferences for care.
Further study of regional variation in end-of-life prac-
tices may provide insights into how end-of-life care may
be improved in general. Communities where aggressive
medical interventions are used sparingly near the end of
life may constitute “laboratories” for examining how med-
ical and quality-of-life considerations may be balanced to
achieve better end-of-life experiences. Conversely, examin-
ation of communities where more aggressive end-of-lifecare is routine may lead to a better understanding of the
patient, provider, and cultural factors that are associated
with such intensive – some might say nonbeneficial –
practices. Other factors that may affect end-of-life care
practices, such as provider-induced demand for services,
the availability and utilization of hospice services, personal
values, and religious beliefs are challenging to study, but
may provide valuable insights into regional variation.
The strengths of the current study include the examin-
ation of a nearly “100% sample” from the USRDS’s national
data spanning 15 years, and the examination of regional
variation after adjustment for key demographic variables.
The study also has several potential limitations. First, the
data on discontinuation of dialysis in this study came from
the death notification form utilized by the USRDS. This
form does not provide clinicians with opportunities to
clarify whether dialysis was discontinued with the
intention of allowing natural death to occur, or because
death from another cause was imminent. The indication
that dialysis therapy was discontinued prior to death does
not signify that the patient died from the discontinuation
of dialysis. Second, although the ESRD data reported
to the USRDS is thought to be complete and current,
it was not be possible to determine how many cases of
ESRD deaths occurred but went unreported, and – more
significantly – how many ESRD deaths were reported but
without a record of a decision to terminate dialysis prior
to death. Third, for the entire 15 years examined in the
study, more than 82% of forms had information regarding
discontinuation status. The proportion of death notifica-
tion forms with known dialysis discontinuation status was
homogeneous for all networks during 2000 – 2009, but
greater variation was observed before 2000, suggesting the
potential for bias due to differences either in the charac-
teristics of patients for whom dialysis discontinuation sta-
tus data was not available, or in networks with differences
in reporting. A sensitivity analyses conducted for a 10-year
cohort (2000–2009) compared to the overall 15-year
cohort (1995–2009) showed no appreciable differences
between the cohorts beyond temporal influences consist-
ent with the overall findings of the study. That is, patients
in the 15-year cohort tended to be slightly younger at the
time of death, with slightly earlier withdrawal than those
in the 10-year cohort. The 15-year cohort, which included
5 years of earlier data, was slightly less urbanized than the
10-year cohort, reflecting subtle demographic shifts
that occurred during the observation window. The results
of the multivariate analysis on the 10-year cohort were
also consistent with the outcomes of the results obtained
for the full 15-year cohort, supporting our conclusion that
there is no discernible bias attributable to the differential
in the reporting rates over time. Finally, this study used
ESRD Networks as geographic units of analysis. Accord-
ingly, the effects of provider, facility and community
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regions were not addressed. The effects of such variables
are best assessed using the methods that have been
established for examining small area variation; this was
beyond the scope of the current study.
Conclusions
Discontinuation of dialysis prior to death was common in
the US between 1995 and 2009. The deaths of nearly one
quarter of chronic dialysis patients followed a decision to
discontinue dialysis. Significant regional variation in dis-
continuation rates exists after adjusting for age, race, sex,
and rural–urban status. Further research and analysis is
needed on the cultural and economic factors that affect
regional variation in health services utilization, especially
in regard to the use of expensive medical services near the
end of life.
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